DR

Alpha Tau Medical LtdNASDAQ DRTS Stock Report

Last reporting period 30 Jun, 2023

Updated 18 Nov, 2024

Last price

Market cap $B

0.158

Micro

Exchange

XNAS - Nasdaq

DRTS Stock Analysis

DR

Uncovered

Alpha Tau Medical Ltd is uncovered by Eyestock quantitative analysis.

Market cap $B

0.158

Dividend yield

Shares outstanding

69.134 B

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The firm has one subsidiary Healthcare Capital Corp.

View Section: Eyestock Rating